NR1H4 and Other metabolic disease: Kavita Jadhav et al. used INT-767 to activate FXR and TGR5 receptors through their downstream signaling pathways to achieve the inhibition of adipogenesis to ameliorate metabolic disorders, suggesting that FXR and TGR5 play an essential role in the regulation of metabolism in the organism [107].